Congress will weigh this year whether to continue spending billions of dollars on antidotes for attacks seen as relatively unlikely, but potentially devastating.
Lawmakers helped to establish Project Bioshield in 2004 to incentivize otherwise unprofitable work on treatments for exotic possible terrorism tools, such as anthrax and botulinum toxin. In coming months, though, the decade-old initiative could face unprecedented scrutiny of its funding, in part due to a dearth of chemical, biological, radiological and nuclear attacks in the United States since its launch, says a newly published Congressional Research Service report.
“Congressional policymakers could decide not to fund Project Bioshield,” analyst Frank Gottron said in the assessment. “Given the continued absence of any [WMD] terrorist attacks in the United States since 2001, [they] could deem that the perceived risk of an attack no longer justifies [the] continued investment.”
“Alternatively, policymakers could deem other, more conventional, countermeasure procurement methods sufficient or more efficient than Project Bioshield and redirect funding to those programs,” Gottron wrote.
Congress guaranteed Project Bioshield a steady $560 million in annual funding for its first decade by setting aside billions in advance. The Health and Human Services Department set aside more than half of the program’s 10-year, $5.6 billion “special reserve fund” to acquire treatments for symptoms of a wide variety of potential unconventional assaults. Of the $3.3 billion earmarked for WMD threats, about one-third went toward smallpox drugs, in case the long-eradicated virus is ever rebuilt or released from a rare laboratory stockpile.
Lawmakers last year authorized the program to continue receiving the same amount of money through fiscal 2018. Rather than maintaining its special reserve fund, though, they left funding levels to be determined through the annual appropriations process.
The program received $255 million in fiscal 2014 appropriations, and the Obama administration is seeking $415 million in the upcoming budget cycle.
“The switch to annual appropriations may complicate [the Health and Human Services Department’s] long-term countermeasure development and acquisition planning,” Gottron wrote. “Some developers contend that an advance appropriation helps company management more favorably consider a potential countermeasure when weighing internal investment opportunity costs.”
Lawmakers may ultimately reinstate an approach similar to the 10-year reserve fund, the analyst added.
“Developers might prefer advance appropriations for as long a period as possible,” he wrote. “However, providing an advance appropriation during the current fiscal environment may prove more difficult than in 2003.”
What We're Following See More »
Not to be outdone by Jeffrey Goldberg's recent piece in The Atlantic about President Obama's foreign policy, the New York Times Magazine checks in with a longread on the president's economic legacy. In it, Obama is cognizant that the economic reality--73 straight months of growth--isn't matched by public perceptions. Some of that, he says, is due to a constant drumbeat from the right that "that denies any progress." But he also accepts some blame himself. “I mean, the truth of the matter is that if we had been able to more effectively communicate all the steps we had taken to the swing voter,” he said, “then we might have maintained a majority in the House or the Senate.”
Ronald Reagan's children and political allies took to the media and Twitter this week to chide funnyman Will Ferrell for his plans to play a dementia-addled Reagan in his second term in a new comedy entitled Reagan. In an open letter, Reagan's daughter Patti Davis tells Ferrell, who's also a producer on the movie, “Perhaps for your comedy you would like to visit some dementia facilities. I have—I didn’t find anything comedic there, and my hope would be that if you’re a decent human being, you wouldn’t either.” Michael Reagan, the president's son, tweeted, "What an Outrag....Alzheimers is not joke...It kills..You should be ashamed all of you." And former Rep. Joe Walsh called it an example of "Hollywood taking a shot at conservatives again."
In a sign that she’s ready to put a longer-than-expected primary battle behind her, former Secretary of State Hillary Clinton (D) is no longer going on the air in upcoming primary states. “Team Clinton hasn’t spent a single cent in … California, Indiana, Kentucky, Oregon and West Virginia, while” Sen. Bernie Sanders’ (I-VT) “campaign has spent a little more than $1 million in those same states.” Meanwhile, Sen. Jeff Merkley (D-OR), Sanders’ "lone backer in the Senate, said the candidate should end his presidential campaign if he’s losing to Hillary Clinton after the primary season concludes in June, breaking sharply with the candidate who is vowing to take his insurgent bid to the party convention in Philadelphia.”
The team behind the bestselling "Clinton Cash"—author Peter Schweizer and Breitbart's Stephen Bannon—is turning the book into a movie that will have its U.S. premiere just before the Democratic National Convention this summer. The film will get its global debut "next month in Cannes, France, during the Cannes Film Festival. (The movie is not a part of the festival, but will be shown at a screening arranged for distributors)." Bloomberg has a trailer up, pointing out that it's "less Ken Burns than Jerry Bruckheimer, featuring blood-drenched money, radical madrassas, and ominous footage of the Clintons."
Conrad Burns, the colorful livestock auctioneer and radio executive from Montana who served three terms as a senator, died on Thursday at age 81. Burns "was ousted from office in 2006 under the specter of scandal after developing close ties to "super-lobbyist" Jack Abramoff," although no charges were ever filed.